Response Genetics Inc
Response Genetics, Inc., a life sciences company, researches, develops, markets, and sells pharmacogenomic tests for use in the treatment of cancer in the United States, Europe, and internationally. The company offers tests for measuring predictive factors for therapy response in tumor tissue samples. It provides testing services for non-small cell lung cancer, colorectal cancer, gastric and gast… Read more
Market Cap & Net Worth: Response Genetics Inc (RGDXQ)
Response Genetics Inc (PINK:RGDXQ) has a market capitalization of $1.37K ($1.37K) as of March 19, 2026. Listed on the PINK stock exchange, this USA-based company holds position #51162 globally and #15833 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Response Genetics Inc's stock price $0.00 by its total outstanding shares 13652274 (13.65 Million).
Response Genetics Inc Market Cap History: 2015 to 2025
Response Genetics Inc's market capitalization history from 2015 to 2025. Data shows change from $12.29K to $1.37K (-36.16% CAGR).
Response Genetics Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Response Genetics Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.00x
Response Genetics Inc's market cap is 0.00 times its annual revenue
0.69x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $12.29K | $18.04 Million | -$20.18 Million | 0.00x | N/A |
Competitor Companies of RGDXQ by Market Capitalization
Companies near Response Genetics Inc in the global market cap rankings as of March 19, 2026.
Key companies related to Response Genetics Inc by market ranking:
- Thermo Fisher Scientific Inc (NYSE:TMO): Ranked #90 globally with a market cap of $177.20 Billion USD.
- Danaher Corporation (NYSE:DHR): Ranked #151 globally with a market cap of $122.79 Billion USD.
- IDEXX Laboratories Inc (NASDAQ:IDXX): Ranked #466 globally with a market cap of $46.38 Billion USD.
- Lonza Group Ltd (PINK:LZAGF): Ranked #511 globally with a market cap of $41.73 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #90 | Thermo Fisher Scientific Inc | NYSE:TMO | $177.20 Billion | $472.71 |
| #151 | Danaher Corporation | NYSE:DHR | $122.79 Billion | $195.21 |
| #466 | IDEXX Laboratories Inc | NASDAQ:IDXX | $46.38 Billion | $586.98 |
| #511 | Lonza Group Ltd | PINK:LZAGF | $41.73 Billion | $596.13 |
Response Genetics Inc Historical Marketcap From 2015 to 2025
Between 2015 and today, Response Genetics Inc's market cap moved from $12.29K to $ 1.37K, with a yearly change of -36.16%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $1.37K | 0.00% |
| 2024 | $1.37K | 0.00% |
| 2023 | $1.37K | 0.00% |
| 2021 | $1.37K | -96.67% |
| 2020 | $40.96K | +7.14% |
| 2019 | $38.23K | +154.55% |
| 2018 | $15.02K | +57.14% |
| 2017 | $9.56K | -50.00% |
| 2016 | $19.11K | +55.56% |
| 2015 | $12.29K | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Response Genetics Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $1.37K USD |
| MoneyControl | $1.37K USD |
| MarketWatch | $1.37K USD |
| marketcap.company | $1.37K USD |
| Reuters | $1.37K USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.